Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01747837 · ClinicalTrials.gov registry record · NA

REnal SympathetiC Denervation to sUpprEss Tachyarrhythmias in ICD Recipients

A NA study of Ventricular Tachycardia, sponsored by Vivek Reddy.

Completed
Registry status
NA
Development phase
48
Enrollment target
4
Study locations

NCT01747837 is a NA study of Ventricular Tachycardia that has completed, run by Vivek Reddy. The registered enrollment target is 48 participants, below the 287-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (83% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01747837, a NA study of Ventricular Tachycardia, has completed, sponsored by Vivek Reddy.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target
4
Study locations

Study Summary

The objective of this trial is to determine the efficacy and safety of adjunctive catheter-based renal sympathetic denervation (RSDN) in the primary prevention of implantable cardioverter defibrillator (ICD) therapy in patients with ischemic or non-ischemic ventricular dysfunction, who are to receive an ICD for either i) secondary prevention, or ii) primary prevention + inducible ventricular tachycardia (VT) by programmed ventricular stimulation at the time of ICD implantation. These patients will be randomized to ICD alone or ICD + RSDN.

Conditions Studied

Ventricular Tachycardia

Interventions

  • DEVICE Boston Scientific Vessix Renal Denervation System

Study Locations (4)

Other

  • Na Homolce Hospital - Prague
  • Academician E.N. Meshalkin Novosibirsk State Budget Research Institute of Circulation Pathology - Novosibirsk

New York

  • Mount Sinai Hospital - New York

Texas

  • Texas Cardiac - Austin

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2015-10-22
Est. Completion 2019-01-09
Phase NA

Sponsor

Vivek Reddy

20 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01747837

The ClinicalTrials.gov registry entry for NCT01747837 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 287-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (83% lower). The listed sponsor is Vivek Reddy, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ventricular Tachycardia appearing as the primary indexed condition, and to 1 intervention - of which Boston Scientific Vessix Renal Denervation System is the first listed.

NCT01747837 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Other, New York, Texas.

Frequently Asked Questions

What is clinical trial NCT01747837 about?

NCT01747837 is a clinical study titled "REnal SympathetiC Denervation to sUpprEss Tachyarrhythmias in ICD Recipients". The objective of this trial is to determine the efficacy and safety of adjunctive catheter-based renal sympathetic denervation (RSDN) in the primary prevention of implantable cardioverter defibrillator (ICD) therapy in patients with ischemic or non-ischemic ventricular dysfunction, who are to receiv...

What is the current status of trial NCT01747837?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2015-10-22. Estimated completion is 2019-01-09.

What conditions does trial NCT01747837 study?

This clinical trial studies the following conditions: Ventricular Tachycardia.

What interventions are being tested in trial NCT01747837?

The interventions under investigation include: Boston Scientific Vessix Renal Denervation System (DEVICE).

Who is sponsoring clinical trial NCT01747837?

This trial is sponsored by Vivek Reddy, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01747837 being conducted?

This trial has 4 study locations across New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ventricular Tachycardia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ventricular Tachycardia

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.